The high disease manifestation heterogeneity is observed despite the primary genetic reason being mostly obvious, residing in inactivating mutations in SERPING1 (HAE-C1INH, types I and II), or FXII (HAE with normal C1 inhibitor, nC1-INH HAE). This evidence concerns the gene SERPING1 and hereditary angioedema.